MAO Inhibitors
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Antidepressants are among the most commonly prescribed medications in primary care, yet a new antidepressant which became available over a year ago has not been widely used. Dr. Paul Markowitz discusses MAO inhibitors and dispels many of the myths surrounding using them.
Overview
Antidepressants are among the most commonly prescribed medications in primary care, yet a new antidepressant which became available over a year ago has not been widely used. Dr. Paul Markowitz discusses MAO inhibitors and dispels many of the myths surrounding using them.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Level Up Your Skills: Tailoring Management of HF
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?